Over time, these approaches can come with their own drawbacks, such as gut lining damage or liver stress
We agree with commenters that the reporting burden associated with structural measures is typically small
Look for platforms that give transparent pricing before you commit
Absolute contraindications to GLP-1 receptor agonists include: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 Previous serious hypersensitivity reaction to the specific GLP-1 drug Pregnancy and breastfeeding (for medications approved for weight management: Wegovy, Saxenda, and Zepbound) Patients should maintain age-appropriate cancer screening regardless of GLP-1 use
However, studies have yielded inconsistent results [115, 116]
5, 2024 (HealthDay News) Low-income patients access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found